Panacea Life Sciences Holdings annual gross margin
2019
2020
2021
2022
2023
Panacea Life Sciences Holdings Gross Margin Growth & History (PLSH)
Panacea Life Sciences Holdings's gross margin was 47.04% for fiscal 2023.
View full Panacea Life Sciences Holdings company overviewPanacea Life Sciences Holdings annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2023 | 2023-12-31 | 47.04% | +22.68 pp |
| 2022 | 2022-12-31 | 24.37% | −1.88 pp |
| 2021 | 2021-12-31 | 26.25% | +4.10 pp |
| 2020 | 2020-12-31 | 22.15% | +514.07 pp |
| 2019 | 2019-12-31 | −491.92% | — |
Panacea Life Sciences Holdings quarterly gross margin
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q1.25
Q2.25
Q3.25
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q3 2025 | 2025-09-30 | 93.94% | — |
| Q2 2025 | 2025-06-30 | 85.43% | — |
| Q1 2025 | 2025-03-31 | 46.68% | −16.38 pp |
| Q1 2024 | 2024-03-31 | 63.06% | +29.76 pp |
| Q4 2023 | 2023-12-31 | 56.94% | +22.83 pp |
| Q3 2023 | 2023-09-30 | 42.15% | +29.23 pp |
| Q2 2023 | 2023-06-30 | 50.81% | +21.43 pp |
| Q1 2023 | 2023-03-31 | 33.30% | +11.78 pp |
| Q4 2022 | 2022-12-31 | 34.11% | +17.47 pp |
| Q3 2022 | 2022-09-30 | 12.92% | −35.21 pp |
| Q2 2022 | 2022-06-30 | 29.39% | +8.70 pp |
| Q1 2022 | 2022-03-31 | 21.52% | — |
| Q4 2021 | 2021-12-31 | 16.64% | −122.05 pp |
| Q3 2021 | 2021-09-30 | 48.13% | +164.39 pp |
| Q2 2021 | 2021-06-30 | 20.69% | −31.01 pp |
| Q4 2020 | 2020-12-31 | 138.69% | +1091.43 pp |
| Q3 2020 | 2020-09-30 | −116.26% | −49.32 pp |
| Q2 2020 | 2020-06-30 | 51.70% | +92.30 pp |
| Q1 2020 | 2020-03-31 | −67.49% | −88.65 pp |
| Q4 2019 | 2019-12-31 | −952.74% | — |
| Q3 2019 | 2019-09-30 | −66.94% | — |
| Q2 2019 | 2019-06-30 | −40.60% | — |
| Q1 2019 | 2019-03-31 | 21.15% | — |
Panacea Life Sciences Holdings gross margin trends
Between the periods ended 2019-12-31 and 2023-12-31, Panacea Life Sciences Holdings's gross margin increased from −491.92% to 47.04%, a change of +538.96 percentage points. The latest reported quarter, Q3 2025, shows 93.94%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Panacea Life Sciences Holdings source filings ↗